An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation

Eva Hesping1, Tina S. Skinner-Adams1, Gillian M. Fisher1, Thomas Kurz2, Katherine T. Andrews1
1Griffith Institute for Drug Discovery, Griffith University, Brisbane, Australia
2Institut für Pharmazeutische und Medizinische Chemie, Heinrich Heine Universität, Düsseldorf, Germany

Tài liệu tham khảo

Agbor-Enoh, 2009, Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice, Antimicrob. Agents Chemother., 53, 1727, 10.1128/AAC.00729-08 Andrews, 2012, Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitors, PLoS One, 7, 10.1371/journal.pone.0031847 Andrews, 2012, HDAC inhibitors in parasitic diseases, Immunol. Cell Biol., 90, 66, 10.1038/icb.2011.97 Andrews, 2012, Towards histone deacetylase inhibitors as new antimalarial drugs, Curr. Pharmaceut. Des., 18, 3467 Andrews, 2008, Potent antimalarial activity of histone deacetylase inhibitor analogues, Antimicrob. Agents Chemother., 52, 1454, 10.1128/AAC.00757-07 Andrews, 2009, Targeting histone deacetylase inhibitors for anti-malarial therapy, Curr. Top. Med. Chem., 9, 292, 10.2174/156802609788085313 Aurrecoechea, 2009, PlasmoDB: a functional genomic database for malaria parasites, Nucleic Acids Res., 37, D539, 10.1093/nar/gkn814 Butler, 2010, Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A, J. Am. Chem. Soc., 132, 10842, 10.1021/ja102758v Campas-Moya, 2009, Romidepsin for the treatment of cutaneous T-cell lymphoma, Drugs Today (Barc)., 45, 787, 10.1358/dot.2009.45.11.1437052 Chenet, 2016, Independent emergence of the Plasmodium falciparum kelch propeller domain mutant Allele C580Y in Guyana, J. Infect. Dis., 213, 1472, 10.1093/infdis/jiv752 Chua, 2017, Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth, Int J Parasitol Drugs Drug Resist, 7, 42, 10.1016/j.ijpddr.2016.12.005 Coetzee, 2020, Epigenetic inhibitors target multiple stages of Plasmodium falciparum parasites, Sci. Rep., 10, 2355, 10.1038/s41598-020-59298-4 Coleman, 2014, A Plasmodium falciparum histone deacetylase regulates antigenic variation and gametocyte conversion, Cell Host Microbe, 16, 177, 10.1016/j.chom.2014.06.014 Darkin-Rattray, 1996, Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase, Proc. Natl. Acad. Sci. U. S. A., 93, 13143, 10.1073/pnas.93.23.13143 Duraisingh, 2005, Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum, Cell, 121, 13, 10.1016/j.cell.2005.01.036 Engel, 2015, Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites, Int J Parasitol Drugs Drug Resist, 5, 117, 10.1016/j.ijpddr.2015.05.004 Fioravanti, 2020, Targeting histone acetylation/deacetylation in parasites: an update (2017-2020), Curr. Opin. Chem. Biol., 57, 65, 10.1016/j.cbpa.2020.05.008 Freitas-Junior, 2005, Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites, Cell, 121, 25, 10.1016/j.cell.2005.01.037 Furumai, 2002, FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases, Canc. Res., 62, 4916 Garnock-Jones, 2015, Panobinostat: first global approval, Drugs, 75, 695, 10.1007/s40265-015-0388-8 Giannini, 2015, Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite, Bioorg. Med. Chem. Lett, 25, 459, 10.1016/j.bmcl.2014.12.051 Goracci, 2016, A rational approach for the identification of non-hydroxamate HDAC6-selective inhibitors, Sci. Rep., 6, 29086, 10.1038/srep29086 Grant, 2007, Vorinostat, Nat. Rev. Drug Discov., 6, 21, 10.1038/nrd2227 Gupta, 2017, Histone 4 lysine 8 acetylation regulates proliferation and host-pathogen interaction in Plasmodium falciparum, Epigenet. Chromatin, 10, 40, 10.1186/s13072-017-0147-z Hailu, 2017, Lysine deacetylase inhibitors in parasites: past, present, and future perspectives, J. Med. Chem., 60, 4780, 10.1021/acs.jmedchem.6b01595 Hollin, 2020, Dynamic chromatin structure and epigenetics control the fate of malaria parasites, Trends Genet., S0168–9525 Kanyal, 2017, Genome-wide survey and phylogenetic analysis of histone acetyltransferases and histone deacetylases of Plasmodium falciparum, FEBS J., 285, 1767, 10.1111/febs.14376 Khan, 2012, HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications, Immunol. Cell Biol., 90, 85, 10.1038/icb.2011.100 Lambros, 1979, Synchronization of Plasmodium falciparum erythrocytic stages in culture, J. Parasitol., 65, 418, 10.2307/3280287 Lu, 2017, Emergence of indigenous artemisinin-resistant Plasmodium falciparum in Africa, N. Engl. J. Med., 376, 991, 10.1056/NEJMc1612765 Mackwitz, 2019, Structure-activity and structure-toxicity relationships of peptoid-based histone deacetylase inhibitors with dual-stage antiplasmodial activity, ChemMedChem, 14, 912, 10.1002/cmdc.201800808 Melesina, 2015, Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors, J. Mol. Graph. Model., 62, 342, 10.1016/j.jmgm.2015.10.006 Merrick, 2007, Plasmodium falciparum Sir2: an unusual sirtuin with dual histone deacetylase and ADP-ribosyltransferase activity, Eukaryot. Cell, 6, 2081, 10.1128/EC.00114-07 Miao, 2006, The malaria parasite Plasmodium falciparum histones: organization, expression, and acetylation, Gene, 369, 53, 10.1016/j.gene.2005.10.022 Moradei, 2005, Histone deacetylase inhibitors: latest developments, trends and prospects, Curr Med Chem Anticancer Agents, 5, 529, 10.2174/1568011054866946 Ontoria, 2016, Discovery of a selective series of inhibitors of Plasmodium falciparum HDACs, ACS Med. Chem. Lett., 7, 454, 10.1021/acsmedchemlett.5b00468 Prince, 2013, Romidepsin for cutaneous T-cell lymphoma, Future Oncol., 9, 1819, 10.2217/fon.13.220 Rasmussen, 2017, Artemisinin-Resistant Plasmodium falciparum in Africa, N. Engl. J. Med., 377, 305, 10.1056/NEJMc1705789 Richon, 1998, A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases, Proc. Natl. Acad. Sci. U. S. A., 95, 3003, 10.1073/pnas.95.6.3003 Rosato, 2003, The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1, Canc. Res., 63, 3637 Scuto, 2008, The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells, Blood, 111, 5093, 10.1182/blood-2007-10-117762 Shahbazian, 2007, Functions of site-specific histone acetylation and deacetylation, Annu. Rev. Biochem., 76, 75, 10.1146/annurev.biochem.76.052705.162114 Sumanadasa, 2012, Antimalarial activity of the anticancer histone deacetylase inhibitor SB939, Antimicrob. Agents Chemother., 56, 3849, 10.1128/AAC.00030-12 Tatamiya, 2004, Isozyme-selective activity of the HDAC inhibitor MS-275, Canc. Res., 64 Thompson, 2014, Belinostat approved for use in treating rare lymphoma, Am. J. Health Syst. Pharm., 71, 1328, 10.2146/news140056 Tonkin, 2009, Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum, PLoS Biol., 7, e84, 10.1371/journal.pbio.1000084 Trager, 2005, Human malaria parasites in continuous culture. 1976, J. Parasitol., 91, 484, 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2 Ungerstedt, 2005, Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors, Proc. Natl. Acad. Sci. U. S. A., 102, 673, 10.1073/pnas.0408732102 Uwimana, 2020, Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda, Nat. Med., 26, 1602, 10.1038/s41591-020-1005-2 van der Pluijm, 2019, Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study, Lancet Infect. Dis., 19, 952, 10.1016/S1473-3099(19)30391-3 Vanheer, 2020, Activity of epigenetic inhibitors against Plasmodium falciparum asexual and sexual blood stages, Antimicrob. Agents Chemother., 64, 10.1128/AAC.02523-19 Vigushin, 2001, Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo, Clin. Canc. Res., 7, 971 Walliker, 1987, Genetic analysis of the human malaria parasite Plasmodium falciparum, Science, 236, 1661, 10.1126/science.3299700 Zhang, 1999, A simple statistical parameter for use in evaluation and validation of high throughput screening assays, J. Biomol. Screen, 4, 67, 10.1177/108705719900400206 Zhang, 2018, Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis, Science, 360, 10.1126/science.aap7847